AbbVie Inc. (ABBV) vs Target Corporation (TGT)
A side-by-side comparison of AbbVie Inc. and Target Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
Different business models: ABBV is classified in Healthcare; TGT is classified in Consumer Defensive. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
ABBV
AbbVie Inc.
$263.48HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
TGT
Target Corporation
$144.18Consumer DefensiveDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — ABBV vs TGT
growth of $100 · dividends reinvested · last 14yABBV +1164.7%TGT +238.2%ABBV compounded faster
ABBV TGT
ABBV vs TGT: by the numbers
- •ABBV is the larger company ($465.51B vs $65.49B market cap).
- •TGT trades at the lower trailing earnings multiple (18.54 vs 125.98 P/E), one valuation lens rather than an overall verdict.
- •ABBV converts more revenue to profit (5.79% vs 3.24% net margin).
- •ABBV grew revenue faster over the past five years (4.59% vs -0.29% CAGR).
- •TGT pays the higher dividend yield (3.25% vs 2.62%).
Metrics side by side
Valuation
| Metric | ABBV | TGT |
|---|---|---|
| P/E ratio | 125.98 | 18.54 |
| Forward P/E | N/A | 19.22 |
| P/S ratio | 7.26 | 0.60 |
| P/B ratio | 16.57 | 3.90 |
| EV / EBITDA | 20.46 | 9.98 |
| FCF yield | 4.58% | 4.89% |
Profitability
| Metric | ABBV | TGT |
|---|---|---|
| Gross margin | 70.68% | 28.14% |
| Operating margin | 27.60% | 4.49% |
| Net margin | 5.79% | 3.24% |
| ROE | 13.23% | 21.04% |
| ROIC | 12.97% | 9.76% |
Dividends
| Metric | ABBV | TGT |
|---|---|---|
| Dividend yield | 2.62% | 3.25% |
| Payout ratio | 284.39% | 55.88% |
Growth (annualized)
| Metric | ABBV | TGT |
|---|---|---|
| Revenue CAGR (5Y) | 4.59% | -0.29% |
| EPS CAGR (5Y) | -2.79% | -1.34% |
| FCF CAGR (5Y) | 3.24% | -17.01% |
| Total return CAGR (5Y) | 21.24% | -8.75% |
Frequently asked
- Which has the lower trailing P/E, ABBV or TGT?
- TGT has the lower trailing P/E: ABBV trades at 125.98 and TGT at 18.54. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ABBV or TGT?
- Over the past five years, ABBV grew revenue faster — ABBV at a 4.59% CAGR versus TGT at -0.29%.
- Does ABBV or TGT pay a bigger dividend?
- ABBV yields 2.62% and TGT yields 3.25% based on trailing dividends and the latest price.
- Is ABBV or TGT more profitable?
- ABBV runs the higher net margin — ABBV at 5.79% versus TGT at 3.24%.
- How have ABBV and TGT total returns compared?
- Over the past 10 years, ABBV delivered 19.57% and TGT delivered 9.69% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbbVie P/E ratioTarget P/E ratioAbbVie dividend yieldTarget dividend yieldAbbVie ROETarget ROEAbbVie operating marginTarget operating marginAbbVie revenue growthTarget revenue growthAbbVie free cash flowTarget free cash flow
AbbVie & Target appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.